Intelligent Medicine Acquisition Corp.

Status: Liquidated
U=S+W/2 W=S@11.5
IPO Proceeds, $M $207.00M
IPO Date Nov 5, 2021
CEO Gregory C. Simon
Left Lead Cantor Fitzgerald
IPO Cash in Trust 102.0%
SPAC Tenor 15 + 7
IPO Sector Healthcare

Life science companies that are using artificial intelligence (“AI”), machine learning (“ML”) and big data to create and power a new model of drug discovery

IPO Geography Global
Target Company N/A
Deal Announced N/A
Deal Size, $M TBD
Deal Sector TBD
Deal Geography TBD
SEC Filings www.sec.gov
Approval Vote TBD
Amendment Vote Feb 8, 2023
Closing Date Apr 27, 2023
IQMD IQMDU IQMDW
Sign up for Free Trial

No credit card required

Sign in for more on Intelligent Medicine Acquisition Corp.:

  • Structure and cap table
  • 5 directors & officers
  • 10 filings and events
  • 1 underwriters

Structure

Sign in to view structure, cap table, and calendar of events.

Team

Name Age Title
Gregory C. Simon 69 Chief Executive Officer, Chief Financial Officer and Director
Jack D. Hidary 52 Chairman
Joseph L. Schocken 74 Director
Patience Marime-Ball 52 Director
Kavita Patel 47 Director

Sign in to view team biographies and more sponsor and affiliate data.

Advisors

Underwriters
Cantor Fitzgerald BR 18,000,000 units
18,000,000 units
Up-Front UW fee 2.00 %
Deferred UW fee
2.00 %

Sign in to view more advisor data.

Filings

Oct 13, 2021 Initial S-1
Nov 4, 2021

Sign In to view filing content.

Nov 8, 2021 424B4 IPO Prospectus
Nov 9, 2021

Sign In to view filing content.

Dec 23, 2021

Sign In to view filing content.

Jan 4, 2023

Sign In to view filing content.

Jan 19, 2023

Sign In to view filing content.

Feb 3, 2023

Sign In to view filing content.

Feb 9, 2023

Sign In to view filing content.

Apr 26, 2023

Sign In to view filing content.

Shareholders